Software - Infrastructure
Compare Stocks
4 / 10Stock Comparison
DAVA vs ACN vs EPAM vs CTSH
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
Information Technology Services
Information Technology Services
DAVA vs ACN vs EPAM vs CTSH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Infrastructure | Information Technology Services | Information Technology Services | Information Technology Services |
| Market Cap | $163M | $112.19B | $5.51B | $24.61B |
| Revenue (TTM) | $755M | $72.11B | $5.56B | $21.41B |
| Net Income (TTM) | $11M | $7.68B | $387M | $2.23B |
| Gross Margin | 24.8% | 32.0% | 28.5% | 32.1% |
| Operating Margin | 3.2% | 14.8% | 9.9% | 15.7% |
| Forward P/E | 4.9x | 13.0x | 7.7x | 9.1x |
| Total Debt | $228M | $8.18B | $144M | $1.57B |
| Cash & Equiv. | $59M | $11.48B | $1.30B | $1.90B |
DAVA vs ACN vs EPAM vs CTSH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Endava plc (DAVA) | 100 | 8.6 | -91.4% |
| Accenture plc (ACN) | 100 | 89.5 | -10.5% |
| EPAM Systems, Inc. (EPAM) | 100 | 43.0 | -57.0% |
| Cognizant Technolog… (CTSH) | 100 | 97.5 | -2.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DAVA vs ACN vs EPAM vs CTSH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DAVA is the clearest fit if your priority is value.
- Lower P/E (4.9x vs 7.7x)
ACN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 14 yrs, beta 0.85, yield 3.2%
- Rev growth 7.4%, EPS growth 6.2%, 3Y rev CAGR 4.2%
- 89.9% 10Y total return vs CTSH's 0.0%
- 10.7% margin vs DAVA's 1.4%
EPAM is the clearest fit if your priority is growth.
- 15.4% revenue growth vs DAVA's 4.3%
CTSH is the #2 pick in this set and the best alternative if sleep-well-at-night and valuation efficiency is your priority.
- Lower volatility, beta 0.75, Low D/E 10.5%, current ratio 2.34x
- PEG 0.75 vs EPAM's 2.07
- Beta 0.75, yield 2.4%, current ratio 2.34x
- Beta 0.75 vs DAVA's 1.82, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.4% revenue growth vs DAVA's 4.3% | |
| Value | Lower P/E (4.9x vs 7.7x) | |
| Quality / Margins | 10.7% margin vs DAVA's 1.4% | |
| Stability / Safety | Beta 0.75 vs DAVA's 1.82, lower leverage | |
| Dividends | 3.2% yield, 14-year raise streak, vs CTSH's 2.4%, (2 stocks pay no dividend) | |
| Momentum (1Y) | -31.7% vs DAVA's -78.3% | |
| Efficiency (ROA) | 11.8% ROA vs DAVA's 1.2%, ROIC 26.8% vs 3.1% |
DAVA vs ACN vs EPAM vs CTSH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DAVA vs ACN vs EPAM vs CTSH — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ACN leads in 3 of 6 categories
CTSH leads 2 • DAVA leads 1 • EPAM leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
ACN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACN is the larger business by revenue, generating $72.1B annually — 95.5x DAVA's $755M. ACN is the more profitable business, keeping 10.7% of every revenue dollar as net income compared to DAVA's 1.4%. On growth, ACN holds the edge at +8.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $755M | $72.1B | $5.6B | $21.4B |
| EBITDAEarnings before interest/tax | $64M | $12.1B | $684M | $3.9B |
| Net IncomeAfter-tax profit | $11M | $7.7B | $387M | $2.2B |
| Free Cash FlowCash after capex | $54M | $12.5B | $544M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +24.8% | +32.0% | +28.5% | +32.1% |
| Operating MarginEBIT ÷ Revenue | +3.2% | +14.8% | +9.9% | +15.7% |
| Net MarginNet income ÷ Revenue | +1.4% | +10.7% | +7.0% | +10.4% |
| FCF MarginFCF ÷ Revenue | +7.1% | +17.3% | +9.8% | +11.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -8.6% | +8.3% | +7.6% | +5.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.9% | +3.9% | +18.8% | +3.7% |
Valuation Metrics
DAVA leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 8.5x trailing earnings, DAVA trades at a 46% valuation discount to EPAM's 15.5x P/E. Adjusting for growth (PEG ratio), CTSH offers better value at 0.94x vs EPAM's 4.18x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $163M | $112.2B | $5.5B | $24.6B |
| Enterprise ValueMkt cap + debt − cash | $393M | $108.9B | $4.4B | $24.3B |
| Trailing P/EPrice ÷ TTM EPS | 8.46x | 14.83x | 15.53x | 11.42x |
| Forward P/EPrice ÷ next-FY EPS est. | 4.92x | 13.00x | 7.69x | 9.07x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.64x | 4.18x | 0.94x |
| EV / EBITDAEnterprise value multiple | 4.66x | 8.60x | 6.74x | 5.95x |
| Price / SalesMarket cap ÷ Revenue | 0.16x | 1.61x | 1.01x | 1.17x |
| Price / BookPrice ÷ Book value/share | 0.31x | 3.53x | 1.60x | 1.67x |
| Price / FCFMarket cap ÷ FCF | 2.50x | 10.32x | 8.99x | 9.48x |
Profitability & Efficiency
ACN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ACN delivers a 23.9% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $2 for DAVA. EPAM carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to DAVA's 0.39x. On the Piotroski fundamental quality scale (0–9), DAVA scores 7/9 vs ACN's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.9% | +23.9% | +10.7% | +14.8% |
| ROA (TTM)Return on assets | +1.2% | +11.8% | +8.1% | +10.9% |
| ROICReturn on invested capital | +3.1% | +26.8% | +15.5% | +18.7% |
| ROCEReturn on capital employed | +3.8% | +24.9% | +13.3% | +21.1% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.39x | 0.25x | 0.04x | 0.10x |
| Net DebtTotal debt minus cash | $169M | -$3.3B | -$1.2B | -$326M |
| Cash & Equiv.Liquid assets | $59M | $11.5B | $1.3B | $1.9B |
| Total DebtShort + long-term debt | $228M | $8.2B | $144M | $1.6B |
| Interest CoverageEBIT ÷ Interest expense | 5.91x | 40.67x | — | 107.78x |
Total Returns (Dividends Reinvested)
CTSH leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTSH five years ago would be worth $7,708 today (with dividends reinvested), compared to $459 for DAVA. Over the past 12 months, CTSH leads with a -31.7% total return vs DAVA's -78.3%. The 3-year compound annual growth rate (CAGR) favors CTSH at -3.4% vs DAVA's -57.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -32.0% | -29.4% | -47.9% | -35.7% |
| 1-Year ReturnPast 12 months | -78.3% | -39.1% | -34.4% | -31.7% |
| 3-Year ReturnCumulative with dividends | -92.2% | -25.5% | -55.0% | -9.8% |
| 5-Year ReturnCumulative with dividends | -95.4% | -29.5% | -77.3% | -22.9% |
| 10-Year ReturnCumulative with dividends | -83.6% | +89.9% | +48.8% | +0.0% |
| CAGR (3Y)Annualised 3-year return | -57.2% | -9.3% | -23.4% | -3.4% |
Risk & Volatility
CTSH leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CTSH is the less volatile stock with a 0.75 beta — it tends to amplify market swings less than DAVA's 1.82 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CTSH currently trades 59.7% from its 52-week high vs DAVA's 19.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.77x | 0.80x | 1.11x | 0.71x |
| 52-Week HighHighest price in past year | $21.81 | $325.71 | $222.53 | $87.03 |
| 52-Week LowLowest price in past year | $3.98 | $173.52 | $99.67 | $50.81 |
| % of 52W HighCurrent price vs 52-week peak | +19.0% | +55.3% | +46.9% | +59.7% |
| RSI (14)Momentum oscillator 0–100 | 39.2 | 33.5 | 22.5 | 23.6 |
| Avg Volume (50D)Average daily shares traded | 290K | 5.7M | 1.3M | 5.9M |
Analyst Outlook
ACN leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DAVA as "Hold", ACN as "Buy", EPAM as "Buy", CTSH as "Hold". Consensus price targets imply 189.9% upside for DAVA (target: $12) vs 51.4% for EPAM (target: $158). For income investors, ACN offers the higher dividend yield at 3.25% vs CTSH's 2.44%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $12.00 | $299.92 | $158.00 | $81.75 |
| # AnalystsCovering analysts | 16 | 53 | 37 | 51 |
| Dividend YieldAnnual dividend ÷ price | — | +3.2% | — | +2.4% |
| Dividend StreakConsecutive years of raises | 2 | 14 | — | 9 |
| Dividend / ShareAnnual DPS | — | $5.85 | — | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | +54.0% | +4.1% | 0.0% | +5.6% |
ACN leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CTSH leads in 2 (Total Returns, Risk & Volatility).
DAVA vs ACN vs EPAM vs CTSH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DAVA or ACN or EPAM or CTSH a better buy right now?
For growth investors, EPAM Systems, Inc.
(EPAM) is the stronger pick with 15. 4% revenue growth year-over-year, versus 4. 3% for Endava plc (DAVA). Endava plc (DAVA) offers the better valuation at 8. 5x trailing P/E (4. 9x forward), making it the more compelling value choice. Analysts rate Accenture plc (ACN) a "Buy" — based on 53 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DAVA or ACN or EPAM or CTSH?
On trailing P/E, Endava plc (DAVA) is the cheapest at 8.
5x versus EPAM Systems, Inc. at 15. 5x. On forward P/E, Endava plc is actually cheaper at 4. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Cognizant Technology Solutions Corporation wins at 0. 75x versus EPAM Systems, Inc. 's 2. 07x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DAVA or ACN or EPAM or CTSH?
Over the past 5 years, Cognizant Technology Solutions Corporation (CTSH) delivered a total return of -22.
9%, compared to -95. 4% for Endava plc (DAVA). Over 10 years, the gap is even starker: ACN returned +90. 1% versus DAVA's -83. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DAVA or ACN or EPAM or CTSH?
By beta (market sensitivity over 5 years), Cognizant Technology Solutions Corporation (CTSH) is the lower-risk stock at 0.
71β versus Endava plc's 1. 77β — meaning DAVA is approximately 150% more volatile than CTSH relative to the S&P 500. On balance sheet safety, EPAM Systems, Inc. (EPAM) carries a lower debt/equity ratio of 4% versus 39% for Endava plc — giving it more financial flexibility in a downturn.
05Which is growing faster — DAVA or ACN or EPAM or CTSH?
By revenue growth (latest reported year), EPAM Systems, Inc.
(EPAM) is pulling ahead at 15. 4% versus 4. 3% for Endava plc (DAVA). On earnings-per-share growth, the picture is similar: Endava plc grew EPS 24. 1% year-over-year, compared to -14. 3% for EPAM Systems, Inc.. Over a 3-year CAGR, DAVA leads at 5. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DAVA or ACN or EPAM or CTSH?
Accenture plc (ACN) is the more profitable company, earning 11.
0% net margin versus 2. 7% for Endava plc — meaning it keeps 11. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTSH leads at 16. 7% versus 4. 1% for DAVA. At the gross margin level — before operating expenses — CTSH leads at 33. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DAVA or ACN or EPAM or CTSH more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Cognizant Technology Solutions Corporation (CTSH) is the more undervalued stock at a PEG of 0. 75x versus EPAM Systems, Inc. 's 2. 07x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Endava plc (DAVA) trades at 4. 9x forward P/E versus 13. 0x for Accenture plc — 8. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DAVA: 189. 9% to $12. 00.
08Which pays a better dividend — DAVA or ACN or EPAM or CTSH?
In this comparison, ACN (3.
2% yield), CTSH (2. 4% yield) pay a dividend. DAVA, EPAM do not pay a meaningful dividend and should not be held primarily for income.
09Is DAVA or ACN or EPAM or CTSH better for a retirement portfolio?
For long-horizon retirement investors, Cognizant Technology Solutions Corporation (CTSH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
71), 2. 4% yield). Endava plc (DAVA) carries a higher beta of 1. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CTSH: -0. 4%, DAVA: -83. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DAVA and ACN and EPAM and CTSH?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DAVA is a small-cap deep-value stock; ACN is a mid-cap deep-value stock; EPAM is a small-cap high-growth stock; CTSH is a mid-cap deep-value stock. ACN, CTSH pay a dividend while DAVA, EPAM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.